The board of Irish pharmaceuticals firm Shire unanimously recommended shareholders accept the offer on the table from Japanese drug maker Takeda. This follows an increase in the cash component of the bid and a price 59.6 per cent higher than it was when the firm first expressed an interest.
To continue reading, register today
to enjoy limited access to the following:
- Daily trading news
- Funds coverage
- Features on big investment themes
- Comprehensive companies coverage
- Economic analysis